Anticoagulant management of atrial fibrillation: the influence of dosing algorithm and recall schedule on time in therapeutic range

被引:1
|
作者
Nantha, Y. Swarna [1 ,2 ]
机构
[1] Seremban Primary Care Clin, Primary Care Res Initiat, Seremban 70300, Negeri Sembilan, Malaysia
[2] Seremban Primary Care Clin, Methods Educ Dept PRIMED, Seremban 70300, Negeri Sembilan, Malaysia
关键词
Atrial fibrillation; dose nomogram; predictors; primary care; TTR; warfarin; INTERNATIONAL NORMALIZED RATIO; PRIMARY-CARE; WARFARIN;
D O I
10.1093/fampra/cmv066
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. The quality of anticoagulation management in atrial fibrillation patients is reflected by the concept of time spent in therapeutic range (TTR). In a primary care setting, the implementation of a dose nomogram could help increase the mean TTR among these patients. Objective. This study compares the influence of a dose algorithm with an integrated recall on TTR prior to standard care and after the implementation of the protocol. Patients and methods. In a purposive sample of patients with AF, an uncontrolled 'before' and 'after' study design was utilized to measure the effects of the protocol on TTR. Demographic data, TTR levels, frequency of international normalized ratio (INR) within therapeutic range, clinician adherence to dose nomogram and warfarin dose changes were captured from consultations at the anticoagulation clinic. Results. A total of 152 patients with AF were entered into the final analysis. The increment in mean TTR in the 'after' intervention phase (2.9%) was not statistically significant (57.5-60.4%, P = 0.252). The increase in the frequency of INR values within therapeutic range in the 'after' intervention phase was significant (50.0-56.0%, P < 0.05) but with a very low effect size (r = 0.04). Conclusions. The implementation of a dose nomogram has the potential of reducing unnecessary dose changes for minor fluctuations in INR levels. The findings in this study needs to be confirmed in a future study involving other indications for anticoagulation, various regional primary care clinics and a larger population size.
引用
收藏
页码:514 / 519
页数:6
相关论文
共 50 条
  • [21] Time in Therapeutic Range and Disease Outcomes in Elderly Japanese Patients With Nonvalvular Atrial Fibrillation
    Inoue, Hiroshi
    Kodani, Eitaro
    Atarashi, Hirotsugu
    Okumura, Ken
    Yamashita, Takeshi
    Okuyama, Yuji
    Origasa, Hideki
    CIRCULATION JOURNAL, 2018, 82 (10) : 2510 - +
  • [22] Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol
    Miguel Rivera-Caravaca, Jose
    Roldar, Vanessa
    Asuncion Esteve-Pastor, Maria
    Valdes, Mariano
    Vicente, Vicente
    Marin, Francisco
    Lip, Gregory Y. H.
    CLINICAL THERAPEUTICS, 2018, 40 (01) : 114 - 122
  • [23] Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation
    Rymer, Jennifer A.
    Chiswell, Karen
    Young, Lauren
    Chiu, Andy
    Liu, Li
    Webb, Laura
    Carlisle, Matthew
    Friedman, Daniel
    Wang, Tracy Y.
    JAMA NETWORK OPEN, 2023, 6 (06)
  • [24] Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation
    Chan, Pak-Hei
    Li, Wen-Hua
    Hai, Jo-Jo
    Chan, Esther W.
    Wong, Ian C. K.
    Tse, Hung-Fat
    Lip, Gregory Y. H.
    Siu, Chung-Wah
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (10) : 1247.e23 - 1247.e28
  • [25] Perioperative management of patients with atrial fibrillation receiving anticoagulant therapy
    Omae, Takeshi
    Koh, Keito
    Kumemura, Masateru
    Sakuraba, Sonoko
    Katsuda, Yosuke
    JOURNAL OF ANESTHESIA, 2019, 33 (04) : 551 - 561
  • [26] Perioperative management of patients with atrial fibrillation receiving anticoagulant therapy
    Takeshi Omae
    Keito Koh
    Masateru Kumemura
    Sonoko Sakuraba
    Yosuke Katsuda
    Journal of Anesthesia, 2019, 33 : 551 - 561
  • [27] Atrial fibrillation ablation with therapeutic INR: implications in heparin intraprocedural dosing
    Bouzin, M.
    Cavaco, D. M.
    Adragao, P.
    Carmo, P.
    Parreira, L.
    Reis-Santos, K.
    Cabrita, D.
    Marcelino, S.
    Abecasis, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 559 - 559
  • [28] Patients Prescribed Warfarin For Active Non-Valvular Atrial Fibrillation, Their Time In The Therapeutic Range (TTR%) And The Recommendations For Novel Anticoagulant Therapy - A Clinical Audit
    Tansey, P.
    Nugent, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S57 - S57
  • [29] Novel Therapeutic Targets in the Management of Atrial Fibrillation
    Abhishek Maan
    Moussa Mansour
    David D. McManus
    Vickas V. Patel
    Alan Cheng
    Jeremy N. Ruskin
    E. Kevin Heist
    American Journal of Cardiovascular Drugs, 2014, 14 : 403 - 421
  • [30] Therapeutic management of atrial fibrillation in the emergency room
    Merodio, JMO
    REVISTA ESPANOLA DE CARDIOLOGIA, 1998, 51 (11): : 890 - 892